Equities

France Bed Holdings Co Ltd

France Bed Holdings Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)1,230.00
  • Today's Change-10.00 / -0.81%
  • Shares traded20.90k
  • 1 Year change-2.15%
  • Beta0.4592
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year France Bed Holdings Co Ltd had relatively flat revenues (58.58bn to 59.15bn), though the company grew net income 15.99% from 2.70bn to 3.13bn. A reduction in the cost of goods sold as a percentage of sales from 46.75% to 46.09% was a component in the net income growth despite flat revenues.
Gross margin54.14%
Net profit margin5.35%
Operating margin7.50%
Return on assets4.93%
Return on equity8.34%
Return on investment6.33%
More ▼

Cash flow in JPYView more

In 2024, France Bed Holdings Co Ltd increased its cash reserves by 27.49%, or 2.85bn. The company earned 7.83bn from its operations for a Cash Flow Margin of 13.23%. In addition the company generated 635.00m cash from financing while 5.62bn was spent on investing.
Cash flow per share239.27
Price/Cash flow per share5.48
Book value per share1,114.40
Tangible book value per share1,071.63
More ▼

Balance sheet in JPYView more

France Bed Holdings Co Ltd has a Debt to Total Capital ratio of 26.05%, a higher figure than the previous year's 14.55%.
Current ratio2.65
Quick ratio2.01
Total debt/total equity0.3523
Total debt/total capital0.2605
More ▼

Growth rates in JPY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 8.33% and 16.10%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)3.26%
Div growth rate (5 year)9.30%
Payout ratio (TTM)23.64%
EPS growth(5 years)5.64
EPS (TTM) vs
TTM 1 year ago
17.52
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.